⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GANX News
Gain Therapeutics, Inc. Common Stock
Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic
globenewswire.com
GANX
Gain Therapeutics to Attend the 2026 Maxim Growth Summit
globenewswire.com
GANX
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
globenewswire.com
GANX
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
GANX